Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer

• Precious Takondwa Makondi,

  Affiliations International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC

  ⨯
• Chi-Ming Chu,

  Affiliation School of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC

  ⨯
• Po-Li Wei ,

  * E-mail: poliwei@tmu.edu.tw (PLW); r5424012@tmu.edu.tw (YJC)

  Affiliations Department of Surgery, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC, Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan, Cancer Research Center, Taipei Medical University Hospital, Taipei, Taiwan, ROC, Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan

  ⨯
• Yu-Jia Chang

  * E-mail: poliwei@tmu.edu.tw (PLW); r5424012@tmu.edu.tw (YJC)

  Affiliations Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC, Cancer Research Center, Taipei Medical University Hospital, Taipei, Taiwan, ROC

  http://orcid.org/0000-0003-3978-3244

  ⨯